


OMI Biomedics Revenue
Research Services • Ptolemeon, 29A, Greece • 1-10 Employees
OMI Biomedics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at OMI Biomedics
Olivera Mitevska
Co-Founder
Company overview
| Headquarters | Ptolemeon, 29A, Thessaloniki, PC 54630, GR |
| Website | |
| NAICS | 5417 |
| Keywords | Genetic Testing, Precision Medicine, Autism Spectrum Disorder, Rare Disease, Liquid Biopsy, Personalized Healthcare, Clinical Genomics, Genomic Medicine, Cancer Genomics, Neurodevelopmental Disorders, Whole Genome Sequencing (Wgs), Whole Exome Sequencing (Wes), Mrd Monitoring |
| Employees | 1-10 |
About OMI Biomedics
We work closely with families and clinicians to uncover the genetic causes of neurodevelopmental conditions, autism spectrum disorders, and challenging cancers. By connecting patients to advanced genetic testing—including whole exome and whole genome sequencing—interpreted by experienced scientists and supported by clinical expertise, we help turn uncertainty into clarity. From diagnosis to treatment planning, our goal is to deliver actionable insights that guide precision medicine and improve patient outcomes. Our trusted international partnerships ensure fast, reliable access to testing, interpretation, and clinical support across Europe and beyond. What We Offer: ✅ Whole Exome & Whole Genome Sequencing ✅ Rare Disease Diagnostics (RareDx Series) ✅ Precision Oncology Testing (OncoCare Series) ✅ Personalized MRD Monitoring ✅ Expert Interpretation & Clinical Support 🌍 Based in Greece | Serving Europe and beyond 🔗 www.omibiomedics.com 📩 info@omibiomedics.com
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
OMI Biomedics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
OMI Biomedics has never raised funding before.
Frequently asked questions
4.8
40,000 users



